Suchergebnisse - "Deykin, Aaron"

1

Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients

von: Hang, Yaming

2016, in: Journal of Pharmacokinetics and Biopharmaceutics

Wird geladen...
2

An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an $ Avonex^{®} $ prefilled syringe in multiple sclerosis subjects

von: Phillips, J Theodore

2011, in: BMC neurology

Wird geladen...
3

An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex

von: Tuccillo Dianne

2011, in: BMC Neurology

Wird geladen...
4

Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis

von: Arnold, Douglas L

2014, in: BMC neurology

Wird geladen...
5

Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

von: Calabresi, Peter A

2014, in: Rejection and modeling of arsenate by nanofiltration: Contributions of convection, diffusion and electromigration to arsenic transport

Wird geladen...
6

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

von: Kapoor, Raju

2018, in: The lancet / Neurology

Wird geladen...
7

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

von: Cadavid, Diego

2019, in: The lancet / Neurology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!